Mirae Asset Global Etfs Holdings Ltd. Moderna, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 295,321 shares of MRNA stock, worth $10.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
295,321
Previous 304,256
2.94%
Holding current value
$10.9 Million
Previous $36.1 Million
45.38%
% of portfolio
0.05%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
952Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.57 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.49 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$944 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$622 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$267 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $14.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...